世界の抗凝固剤市場予測（～2028年）：経口剤、注射剤

• 英文タイトル：Global Anticoagulant Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8733 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

抗凝固剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の抗凝固剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗凝固剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・経口剤、注射剤 用途別セグメントは次のように区分されます。 ・DVT、PE、AF 世界の抗凝固剤市場の主要な市場プレーヤーは以下のとおりです。 ・Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、抗凝固剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な抗凝固剤メーカーの企業概要、2019年～2022年までの抗凝固剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な抗凝固剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別抗凝固剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの抗凝固剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗凝固剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および抗凝固剤の産業チェーンを掲載しています。 ・第13、14、15章では、抗凝固剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticals ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：経口剤、注射剤 ・用途別分析2017年-2028年：DVT、PE、AF ・抗凝固剤の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・抗凝固剤のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・抗凝固剤のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・抗凝固剤の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・抗凝固剤の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Anticoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anticoagulant market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. DVT accounting for % of the Anticoagulant global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anticoagulant include Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anticoagulant market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injectable
Market segment by Application can be divided into
DVT
PE
AF
The key market players for global Anticoagulant market are listed below:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulant, with price, sales, revenue and global market share of Anticoagulant from 2019 to 2022.
Chapter 3, the Anticoagulant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anticoagulant market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anticoagulant.
Chapter 13, 14, and 15, to describe Anticoagulant sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Anticoagulant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anticoagulant Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Anticoagulant Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 DVT
1.3.3 PE
1.3.4 AF
1.4 Global Anticoagulant Market Size & Forecast
1.4.1 Global Anticoagulant Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anticoagulant Sales in Volume (2017-2028)
1.4.3 Global Anticoagulant Price (2017-2028)
1.5 Global Anticoagulant Production Capacity Analysis
1.5.1 Global Anticoagulant Total Production Capacity (2017-2028)
1.5.2 Global Anticoagulant Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anticoagulant Market Drivers
1.6.2 Anticoagulant Market Restraints
1.6.3 Anticoagulant Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Anticoagulant Product and Services
2.1.4 Bayer Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Anticoagulant Product and Services
2.2.4 Boehringer Ingelheim Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bristol-Myers Squibb
2.3.1 Bristol-Myers Squibb Details
2.3.2 Bristol-Myers Squibb Major Business
2.3.3 Bristol-Myers Squibb Anticoagulant Product and Services
2.3.4 Bristol-Myers Squibb Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Daiichi Sankyo
2.4.1 Daiichi Sankyo Details
2.4.2 Daiichi Sankyo Major Business
2.4.3 Daiichi Sankyo Anticoagulant Product and Services
2.4.4 Daiichi Sankyo Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Anticoagulant Product and Services
2.5.4 Pfizer Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Anticoagulant Product and Services
2.6.4 Johnson & Johnson Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Anticoagulant Product and Services
2.7.4 Sanofi Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Anticoagulant Product and Services
2.8.4 AstraZeneca Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Anticoagulant Product and Services
2.9.4 Eli Lilly Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Keryx Biopharmaceuticals
2.10.1 Keryx Biopharmaceuticals Details
2.10.2 Keryx Biopharmaceuticals Major Business
2.10.3 Keryx Biopharmaceuticals Anticoagulant Product and Services
2.10.4 Keryx Biopharmaceuticals Anticoagulant Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anticoagulant Breakdown Data by Manufacturer
3.1 Global Anticoagulant Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anticoagulant Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anticoagulant
3.4 Market Concentration Rate
3.4.1 Top 3 Anticoagulant Manufacturer Market Share in 2021
3.4.2 Top 6 Anticoagulant Manufacturer Market Share in 2021
3.5 Global Anticoagulant Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anticoagulant Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anticoagulant Market Size by Region
4.1.1 Global Anticoagulant Sales in Volume by Region (2017-2028)
4.1.2 Global Anticoagulant Revenue by Region (2017-2028)
4.2 North America Anticoagulant Revenue (2017-2028)
4.3 Europe Anticoagulant Revenue (2017-2028)
4.4 Asia-Pacific Anticoagulant Revenue (2017-2028)
4.5 South America Anticoagulant Revenue (2017-2028)
4.6 Middle East and Africa Anticoagulant Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anticoagulant Sales in Volume by Type (2017-2028)
5.2 Global Anticoagulant Revenue by Type (2017-2028)
5.3 Global Anticoagulant Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anticoagulant Sales in Volume by Application (2017-2028)
6.2 Global Anticoagulant Revenue by Application (2017-2028)
6.3 Global Anticoagulant Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anticoagulant Sales by Type (2017-2028)
7.2 North America Anticoagulant Sales by Application (2017-2028)
7.3 North America Anticoagulant Market Size by Country
7.3.1 North America Anticoagulant Sales in Volume by Country (2017-2028)
7.3.2 North America Anticoagulant Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anticoagulant Sales by Type (2017-2028)
8.2 Europe Anticoagulant Sales by Application (2017-2028)
8.3 Europe Anticoagulant Market Size by Country
8.3.1 Europe Anticoagulant Sales in Volume by Country (2017-2028)
8.3.2 Europe Anticoagulant Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anticoagulant Sales by Type (2017-2028)
9.2 Asia-Pacific Anticoagulant Sales by Application (2017-2028)
9.3 Asia-Pacific Anticoagulant Market Size by Region
9.3.1 Asia-Pacific Anticoagulant Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anticoagulant Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anticoagulant Sales by Type (2017-2028)
10.2 South America Anticoagulant Sales by Application (2017-2028)
10.3 South America Anticoagulant Market Size by Country
10.3.1 South America Anticoagulant Sales in Volume by Country (2017-2028)
10.3.2 South America Anticoagulant Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anticoagulant Sales by Type (2017-2028)
11.2 Middle East & Africa Anticoagulant Sales by Application (2017-2028)
11.3 Middle East & Africa Anticoagulant Market Size by Country
11.3.1 Middle East & Africa Anticoagulant Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anticoagulant Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anticoagulant and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anticoagulant
12.3 Anticoagulant Production Process
12.4 Anticoagulant Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anticoagulant Typical Distributors
13.3 Anticoagulant Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---